BR0215719A - Proteìnas com domìnios bacterianos repetitivos semelhantes a ig (big) presentes em espécies de leptospira - Google Patents
Proteìnas com domìnios bacterianos repetitivos semelhantes a ig (big) presentes em espécies de leptospiraInfo
- Publication number
- BR0215719A BR0215719A BR0215719-5A BR0215719A BR0215719A BR 0215719 A BR0215719 A BR 0215719A BR 0215719 A BR0215719 A BR 0215719A BR 0215719 A BR0215719 A BR 0215719A
- Authority
- BR
- Brazil
- Prior art keywords
- proteins
- big
- present
- leptospira species
- repetitive
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1207—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Cell Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
Abstract
"PROTEìNAS COM DOMìNIOS BACTERIANOS REPETITIVOS SEMELHANTES A Ig (Big) PRESENTES EM ESPéCIES DE LEPTOSPIRA". A invenção esta relacionada a três moléculas isoladas de DNA que codificam para proteínas, BigL1, BigL2 e BigL3, nas bactérias da Leptospira sp que possuem domínios bacterianos do tipo Ig repetitivos (big) e o seu uso em diagnóstico; aplicações terapêuticas e vacina. Segundo esta invenção, as moléculas isoladas que codificam as proteínas BigL1, BigL2 e BigL3 são utilizadas para diagnóstico e prevenção de infecção com espécies de Leptospira, que são capazes de produzir doenças em seres humanos e outros mamíferos, inclusive aqueles de importância veterinária.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/147,299 US20040058323A1 (en) | 2002-05-17 | 2002-05-17 | Proteins with repetitive bacterial-Ig-like (big) domains present in leptospira species |
PCT/BR2002/000072 WO2003098214A1 (en) | 2002-05-17 | 2002-05-20 | Proteins with repetitive bacterial-ig-like (big) domains present in leptospira species |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0215719A true BR0215719A (pt) | 2005-10-04 |
Family
ID=31990111
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0215719-5A BR0215719A (pt) | 2002-05-17 | 2002-05-20 | Proteìnas com domìnios bacterianos repetitivos semelhantes a ig (big) presentes em espécies de leptospira |
Country Status (8)
Country | Link |
---|---|
US (13) | US20040058323A1 (pt) |
JP (1) | JP2006516083A (pt) |
CN (1) | CN1639570A (pt) |
AR (1) | AR039035A1 (pt) |
AT (1) | ATE374943T1 (pt) |
BR (1) | BR0215719A (pt) |
ES (1) | ES2295464T3 (pt) |
NZ (1) | NZ537326A (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2447278B1 (en) | 2002-10-10 | 2015-04-08 | Cornell Research Foundation, Inc. | Novel immunogenic proteins of Leptospira |
KR100760525B1 (ko) * | 2006-04-13 | 2007-10-04 | 김재만 | 병원성 미생물의 무증폭 다중 정량 검출킷트 및 검출방법 |
CN104994870A (zh) | 2012-12-12 | 2015-10-21 | 加利福尼亚大学董事会 | 用于诊断和治疗钩端螺旋体病的方法和蛋白质抗原组合物 |
KR101755231B1 (ko) | 2015-06-30 | 2017-07-10 | 부산대학교 산학협력단 | 토마토 근부위조병 저항성 유전자 선발용 분자마커 |
-
2002
- 2002-05-17 US US10/147,299 patent/US20040058323A1/en not_active Abandoned
- 2002-05-20 ES ES02807433T patent/ES2295464T3/es not_active Expired - Lifetime
- 2002-05-20 AT AT02807433T patent/ATE374943T1/de not_active IP Right Cessation
- 2002-05-20 CN CNA028293053A patent/CN1639570A/zh active Pending
- 2002-05-20 NZ NZ537326A patent/NZ537326A/en not_active IP Right Cessation
- 2002-05-20 BR BR0215719-5A patent/BR0215719A/pt not_active Application Discontinuation
- 2002-05-20 JP JP2004505688A patent/JP2006516083A/ja active Pending
-
2003
- 2003-03-20 AR ARP030100976 patent/AR039035A1/es not_active Application Discontinuation
-
2006
- 2006-01-17 US US11/332,464 patent/US7718183B2/en not_active Expired - Fee Related
-
2010
- 2010-03-19 US US12/728,177 patent/US7935357B2/en not_active Expired - Fee Related
-
2011
- 2011-04-01 US US13/078,879 patent/US8021673B2/en not_active Expired - Fee Related
- 2011-08-23 US US13/216,214 patent/US8124110B2/en not_active Expired - Fee Related
-
2012
- 2012-01-26 US US13/359,354 patent/US8216594B2/en not_active Expired - Fee Related
- 2012-06-15 US US13/525,157 patent/US8445658B2/en not_active Expired - Fee Related
-
2013
- 2013-04-24 US US13/869,660 patent/US8802835B2/en not_active Expired - Fee Related
-
2014
- 2014-05-19 US US14/281,580 patent/US9133250B2/en not_active Expired - Fee Related
-
2015
- 2015-08-05 US US14/819,045 patent/US9346858B2/en not_active Expired - Fee Related
-
2016
- 2016-04-20 US US15/134,168 patent/US9505809B2/en not_active Expired - Fee Related
- 2016-10-25 US US15/334,128 patent/US9932391B2/en not_active Expired - Fee Related
-
2018
- 2018-02-20 US US15/899,805 patent/US20180186867A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20130230903A1 (en) | 2013-09-05 |
US9133250B2 (en) | 2015-09-15 |
US20140308734A1 (en) | 2014-10-16 |
US8802835B2 (en) | 2014-08-12 |
US8021673B2 (en) | 2011-09-20 |
US7718183B2 (en) | 2010-05-18 |
AR039035A1 (es) | 2005-02-02 |
ES2295464T3 (es) | 2008-04-16 |
US20120121639A1 (en) | 2012-05-17 |
US9346858B2 (en) | 2016-05-24 |
US20120270301A1 (en) | 2012-10-25 |
ATE374943T1 (de) | 2007-10-15 |
US20040058323A1 (en) | 2004-03-25 |
US20170037114A1 (en) | 2017-02-09 |
US20150329599A1 (en) | 2015-11-19 |
US20160222069A1 (en) | 2016-08-04 |
US8216594B2 (en) | 2012-07-10 |
JP2006516083A (ja) | 2006-06-22 |
US9932391B2 (en) | 2018-04-03 |
US9505809B2 (en) | 2016-11-29 |
US20180186867A1 (en) | 2018-07-05 |
US7935357B2 (en) | 2011-05-03 |
US8445658B2 (en) | 2013-05-21 |
US8124110B2 (en) | 2012-02-28 |
NZ537326A (en) | 2008-04-30 |
US20110311570A1 (en) | 2011-12-22 |
CN1639570A (zh) | 2005-07-13 |
US20100183656A1 (en) | 2010-07-22 |
US20070110764A1 (en) | 2007-05-17 |
US20110182924A1 (en) | 2011-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY26783A1 (es) | Antígenos de estreptococo. | |
BRPI0410041A (pt) | métodos para tratamento de dor de cabeça de sinusite | |
BR0206689A (pt) | Combinação de probióticos, e, uso desta | |
BR0114105A (pt) | Bactérias de acido lático capazes de reduzir uma tendência do indivìduo para desenvolver reações alérgicas | |
ATE309271T1 (de) | Zusammensetzungen von kollagenbindungsprotein und verfahren zur deren verwendungen | |
BR9909483A (pt) | Derivados de proteìnas ligantes pneumococcal colina para vacinas | |
BR0315228A (pt) | vacinas de polipeptìdeo para ampla proteção contra linhagens meningocócicas hipervirulentas | |
BR0210225A (pt) | Holotoxina do cólera imunogênica mutante, composição imunogênica, método para realçar a resposta imune de um hospedeiro vertebrado a um antìgeno, sequência de dna isolada e purificada, molécula de ácido nucleico, célula hospedeira, método para produzir uma holotoxina do cólera imunogênica mutante, e, uso de uma holotoxina do cólera mutante | |
BR112022022456A2 (pt) | Proteínas de ligação de repetição de anquirina e seus usos | |
BR0016709A (pt) | Agente antiadesão da flora patogênica da pele | |
BRPI1010830A2 (pt) | Sequências de aminoácidos melhoradas direcionadas contra o vírus respiratório sencicial humano (hrsv) e polipetídeos que compreende os mesmos para prevenção e/ou tratamento de infecções do trato respiratório. | |
BR112013010844A2 (pt) | nova endolisina | |
BR0012919A (pt) | Vacina para uso na profilaxia e/ou no tratamento da sìndrome de ponto branco (white spot syndrome) em crustáceos, proteìna estrutural derivada do vìrus da sìndrome de ponto branco, sequência de ácido nucléico, uso de uma proteìna estrutural, composição farmacêutica, anticorpos, vacina ou formulação farmacêutica, e, kit diagnóstico para detecção de wssv | |
BRPI0407533A (pt) | proteìnas de fusão e muteìnas do interferon alfa com propriedades melhoradas | |
BR0006291A (pt) | Bactéria do gênero salmonella, vacina para aproteção de animais contra a salmonelose, uso deuma bactéria, e, processo para a preparação deuma vacina | |
BR0215719A (pt) | Proteìnas com domìnios bacterianos repetitivos semelhantes a ig (big) presentes em espécies de leptospira | |
BR0208786A (pt) | Métodod para identificação de proteìnas de bactérias intracelulares | |
ATE291586T1 (de) | Humanes antibiotisches protein | |
BR0112131A (pt) | Composições farmacêuticas e métodos para uso | |
BR9814958B1 (pt) | Proteína de cimento de tecido, composição farmacêutica, uso da proteína de cimento de tecido, vacina, processos para produção de vacina, para ligação de tecido de animal e para preparação de uma protéina de cimento de tecido | |
ATE311456T1 (de) | Nucleinsäure-moleküle codierend proteine, die die adhäsion von neisseria-zellen an humane zellen vermitteln | |
BR0108792A (pt) | Composto de polipeptìdeo, processo para sua preparação, composição farmacêutica contendo o mesmo, seu uso, método, embalagem comercial e artigo de manufatura | |
DE60235809D1 (de) | Nukleinsäurefreie ghost zusammensetzungen | |
DE60035485D1 (de) | IDENTIFIZIERUNG VON SPEZIFISCHEN DIFFERENZIELL EXPRIMIERTEN ANTIGENEN AUS MYCOBACTERIUM UND MEDIZINISCHE VERWENDUNG DER MYCOBAKTERIUMPROTEINE Rv0068 UND Rv3407 | |
UY26764A1 (es) | Inmunización del ganado lacteo con proteína gapc contra infección por estreptococo. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06G | Technical and formal requirements: other requirements [chapter 6.7 patent gazette] |
Free format text: APRESENTE O DEPOSITANTE TRADUCAO COMPLETA DO PEDIDO, CONFORME DETERMINA O ATO NORMATIVO N 128 DE 19970305, ITENS 9.2 E 9.2.1 |
|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B04C | Request for examination: application reinstated [chapter 4.3 patent gazette] | ||
B08E | Application fees: payment of additional fee required [chapter 8.5 patent gazette] |
Free format text: COMPLEMENTAR 6A ANUIDADE DE ACORDO COM TABELA VIGENTE, REFERENTE A GUIA 220705785553. |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B08H | Application fees: decision cancelled [chapter 8.8 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2138 DE 27/12/2011. |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 25 E 10 DA LPI. |
|
B12B | Appeal against refusal [chapter 12.2 patent gazette] |